NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
7 hedge funds and large institutions have $167K invested in NeuBase Therapeutics, Inc. Common Stock in 2013 Q2 according to their latest regulatory filings, with 7 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
7
Holders Change
+7
Holders Change %
–
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
FNBT
1
FineMark National Bank & Trust
Fort Myers,
Florida
| $125K | 15,667 | +15,667 | New |
|
|
U
2
UBS
Zurich,
Switzerland
| $13K | 1,571 | +1,571 | New |
|
3
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $12K | 1,500 | +1,500 | New |
|
4
First Manhattan
New York
| $10K | 1,667 | +1,667 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $4K | 452 | +452 | New |
|
6
Wells Fargo
San Francisco,
California
| $3K | 334 | +334 | New |
|
|
EWM
7
Edge Wealth Management
New York
| $0 | 1 | +1 | – |
|